NCT04707196 2023-11-24A Study of Abemaciclib in Indian Women With Advanced Breast CancerEli Lilly and CompanyPhase 4 Completed200 enrolled 10 charts
NCT04031885 2021-08-24A Study of Abemaciclib (LY2835219) in Combination With Fulvestrant Compared to Chemotherapy in Women With HR Positive, HER2 Negative Metastatic Breast CancerEli Lilly and CompanyPhase 4 Terminated4 enrolled 9 charts